Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1052 | 2880 | 32.2 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
551 | 3 | FABRY DISEASE//GAUCHER DISEASE//LYSOSOMAL STORAGE DISEASE | 18099 |
491 | 2 | GAUCHER DISEASE//LYSOSOMAL STORAGE DISEASE//MUCOPOLYSACCHARIDOSIS | 15457 |
1052 | 1 | MUCOPOLYSACCHARIDOSIS//MUCOPOLYSACCHARIDOSES//HUNTER SYNDROME | 2880 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MUCOPOLYSACCHARIDOSIS | authKW | 2813199 | 11% | 82% | 325 |
2 | MUCOPOLYSACCHARIDOSES | authKW | 1403001 | 5% | 88% | 150 |
3 | HUNTER SYNDROME | authKW | 1210746 | 4% | 91% | 126 |
4 | HURLER SYNDROME | authKW | 944504 | 3% | 90% | 99 |
5 | LYSOSOMAL DIS UNIT | address | 830886 | 4% | 64% | 123 |
6 | LYSOSOMAL STORAGE DISEASE | authKW | 749496 | 9% | 27% | 261 |
7 | MUCOPOLYSACCHARIDOSIS TYPE II | authKW | 744217 | 3% | 95% | 74 |
8 | ENZYME REPLACEMENT THERAPY | authKW | 638215 | 8% | 26% | 234 |
9 | MAROTEAUX LAMY SYNDROME | authKW | 625442 | 2% | 100% | 59 |
10 | ALPHA L IDURONIDASE | authKW | 585724 | 2% | 94% | 59 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Genetics & Heredity | 23761 | 38% | 0% | 1093 |
2 | Medicine, Research & Experimental | 12507 | 25% | 0% | 723 |
3 | Endocrinology & Metabolism | 4389 | 16% | 0% | 459 |
4 | Pediatrics | 3921 | 13% | 0% | 388 |
5 | Medical Laboratory Technology | 2282 | 5% | 0% | 141 |
6 | Biotechnology & Applied Microbiology | 467 | 7% | 0% | 197 |
7 | Biochemistry & Molecular Biology | 322 | 13% | 0% | 385 |
8 | Ophthalmology | 309 | 3% | 0% | 99 |
9 | Clinical Neurology | 197 | 5% | 0% | 150 |
10 | Pathology | 192 | 3% | 0% | 87 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LYSOSOMAL DIS UNIT | 830886 | 4% | 64% | 123 |
2 | WILLINK BIOCHEM GENET UNIT | 224912 | 2% | 34% | 63 |
3 | AMSTERDAM LYSOSOME SPHINX | 193362 | 1% | 79% | 23 |
4 | MED GENET SERV | 136560 | 3% | 16% | 79 |
5 | ERRO INNATOS METAB | 66045 | 0% | 69% | 9 |
6 | STUDY INBORN ERRORS METAB | 62946 | 0% | 42% | 14 |
7 | ANTHROPOMETRY | 54516 | 0% | 86% | 6 |
8 | METAB DIS H7 270 | 53004 | 0% | 100% | 5 |
9 | STEM CELL NEUROTHER IES | 47700 | 0% | 75% | 6 |
10 | LYSOSOMAL STORAGE DIS | 47494 | 0% | 41% | 11 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR GENETICS AND METABOLISM | 173511 | 8% | 7% | 226 |
2 | JOURNAL OF INHERITED METABOLIC DISEASE | 81800 | 6% | 4% | 187 |
3 | ORPHANET JOURNAL OF RARE DISEASES | 14451 | 1% | 4% | 39 |
4 | HUMAN MUTATION | 10509 | 2% | 2% | 63 |
5 | MOLECULAR THERAPY | 8961 | 2% | 2% | 55 |
6 | PEDIATRIC ENDOCRINOLOGY REVIEWS PER | 7052 | 0% | 8% | 8 |
7 | CLINICA CHIMICA ACTA | 4217 | 2% | 1% | 67 |
8 | EXPERT OPINION ON ORPHAN DRUGS | 3454 | 0% | 3% | 12 |
9 | CLINICAL GENETICS | 3267 | 1% | 1% | 40 |
10 | HUMAN GENE THERAPY | 3200 | 1% | 1% | 32 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MUCOPOLYSACCHARIDOSIS | 2813199 | 11% | 82% | 325 | Search MUCOPOLYSACCHARIDOSIS | Search MUCOPOLYSACCHARIDOSIS |
2 | MUCOPOLYSACCHARIDOSES | 1403001 | 5% | 88% | 150 | Search MUCOPOLYSACCHARIDOSES | Search MUCOPOLYSACCHARIDOSES |
3 | HUNTER SYNDROME | 1210746 | 4% | 91% | 126 | Search HUNTER+SYNDROME | Search HUNTER+SYNDROME |
4 | HURLER SYNDROME | 944504 | 3% | 90% | 99 | Search HURLER+SYNDROME | Search HURLER+SYNDROME |
5 | LYSOSOMAL STORAGE DISEASE | 749496 | 9% | 27% | 261 | Search LYSOSOMAL+STORAGE+DISEASE | Search LYSOSOMAL+STORAGE+DISEASE |
6 | MUCOPOLYSACCHARIDOSIS TYPE II | 744217 | 3% | 95% | 74 | Search MUCOPOLYSACCHARIDOSIS+TYPE+II | Search MUCOPOLYSACCHARIDOSIS+TYPE+II |
7 | ENZYME REPLACEMENT THERAPY | 638215 | 8% | 26% | 234 | Search ENZYME+REPLACEMENT+THERAPY | Search ENZYME+REPLACEMENT+THERAPY |
8 | MAROTEAUX LAMY SYNDROME | 625442 | 2% | 100% | 59 | Search MAROTEAUX+LAMY+SYNDROME | Search MAROTEAUX+LAMY+SYNDROME |
9 | ALPHA L IDURONIDASE | 585724 | 2% | 94% | 59 | Search ALPHA+L+IDURONIDASE | Search ALPHA+L+IDURONIDASE |
10 | SANFILIPPO SYNDROME | 548615 | 2% | 89% | 58 | Search SANFILIPPO+SYNDROME | Search SANFILIPPO+SYNDROME |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KHAN, S , ALMECIGA-DIAZ, CJ , SAWAMOTO, K , MACKENZIE, WG , THEROUX, MC , PIZARRO, C , MASON, RW , ORII, T , TOMATSU, S , (2017) MUCOPOLYSACCHARIDOSIS IVA AND GLYCOSAMINOGLYCANS.MOLECULAR GENETICS AND METABOLISM. VOL. 120. ISSUE 1-2. P. 78 -95 | 113 | 94% | 0 |
2 | LANGEREIS, EJ , VAN VLIES, N , WIJBURG, FA , (2015) DIAGNOSIS, CLASSIFICATION AND TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE I.EXPERT OPINION ON ORPHAN DRUGS. VOL. 3. ISSUE 3. P. 307 -320 | 125 | 83% | 0 |
3 | PECK, SH , CASAL, ML , MALHOTRA, NR , FICICIOGLU, C , SMITH, LJ , (2016) PATHOGENESIS AND TREATMENT OF SPINE DISEASE IN THE MUCOPOLYSACCHARIDOSES.MOLECULAR GENETICS AND METABOLISM. VOL. 118. ISSUE 4. P. 232 -243 | 128 | 74% | 0 |
4 | JAKOBKIEWICZ-BANECKA, J , GABIG-CIMINSKA, M , KLOSKA, A , MALINOWSKA, M , PIOTROWSKA, E , BANECKA-MAJKUTEWICZ, Z , BANECKI, B , WEGRZYN, A , WEGRZYN, G , (2016) GLYCOSAMINOGLYCANS AND MUCOPOLYSACCHARIDOSIS TYPE III.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 21. ISSUE . P. 1393 -1409 | 90 | 95% | 1 |
5 | VALSTAR, MJ , RUIJTER, GJG , VAN DIGGELEN, OP , POORTHUIS, BJ , WIJBURG, FA , (2008) SANFILIPPO SYNDROME: A MINI-REVIEW.JOURNAL OF INHERITED METABOLIC DISEASE. VOL. 31. ISSUE 2. P. 240 -252 | 94 | 92% | 109 |
6 | NOH, H , LEE, JI , (2014) CURRENT AND POTENTIAL THERAPEUTIC STRATEGIES FOR MUCOPOLYSACCHARIDOSES.JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. VOL. 39. ISSUE 3. P. 215-224 | 93 | 89% | 13 |
7 | TOMATSU, S , ALMECIGA-DIAZ, CJ , MONTANO, AM , YABE, H , TANAKA, A , DUNG, VC , GIUGLIANI, R , KUBASKI, F , MASON, RW , YASUDA, E , ET AL (2015) THERAPIES FOR THE BONE IN MUCOPOLYSACCHARIDOSES.MOLECULAR GENETICS AND METABOLISM. VOL. 114. ISSUE 2. P. 94 -109 | 96 | 83% | 6 |
8 | BRAUNLIN, EA , HARMATZ, PR , SCARPA, M , FURLANETTO, B , KAMPMANN, C , LOEHR, JP , PONDER, KP , ROBERTS, WC , ROSENFELD, HM , GIUGLIANI, R , (2011) CARDIAC DISEASE IN PATIENTS WITH MUCOPOLYSACCHARIDOSIS: PRESENTATION, DIAGNOSIS AND MANAGEMENT.JOURNAL OF INHERITED METABOLIC DISEASE. VOL. 34. ISSUE 6. P. 1183 -1197 | 96 | 86% | 32 |
9 | MITCHELL, J , BERGER, KI , BORGO, A , BRAUNLIN, EA , BURTON, BK , GHOTME, KA , KIRCHER, SG , MOLTER, D , ORCHARD, PJ , PALMER, J , ET AL (2016) UNIQUE MEDICAL ISSUES IN ADULT PATIENTS WITH MUCOPOLYSACCHARIDOSES.EUROPEAN JOURNAL OF INTERNAL MEDICINE. VOL. 34. ISSUE . P. 2 -10 | 87 | 94% | 0 |
10 | VALAYANNOPOULOS, V , NICELY, H , HARMATZ, P , TURBEVILLE, S , (2010) MUCOPOLYSACCHARIDOSIS VI.ORPHANET JOURNAL OF RARE DISEASES. VOL. 5. ISSUE . P. - | 81 | 92% | 87 |
Classes with closest relation at Level 1 |